参考文献/References:
[1] Heneka MT,Carson MJ,El Khoury J,et al.Neuroinflammation in Alzheimer's disease[J].The Lancet Neurology,2015,14(4):388-405.
[2] Sevigny J,Chiao P,Bussière T,et al.The antibody aducanumab reduces Aβ plaques in Alzheimer's disease[J].Nature,2016,537(7618):50.
[3] 赵若杞.阿尔茨海默症病理标志物分子影像学研究进展[J].陕西医学杂志,2021,50(3):381-385.
[4] Thapa S,Bhusal K.SUN-545 A Rare Case of Resistance to thyroid hormone due to novel mutation in THRB gene mistreated as hyperthyroidism[J].Journal of the Endocrine Society,2019,3(s1):547-545.
[5] Dikalova AE,Itani HA,Nazarewicz RR,et al.Sirt3 impairment and SOD2 hyperacetylation in vascular oxidative stress and hypertension[J].Circulation Research,2017,121(5):564-574.
[6] Mc-Donnell E,Peterson BS,Bomze HM,et al.Sirt3 regulates progression and development of diseases of aging[J].Trends in Endocrinology & Metabolism,2015,26(9):486-492.
[7] Yu W,Denu RA,Krautkramer KA,et al.Loss of Sirt3 provides growth advantage for B cell malignancies[J].Journal of Biological Chemistry,2016,291(7):3268-3279.
[8] Shi H,Deng HX,Gius D,et al.Sirt3 Protects dopaminergic neurons from mitochondrial oxidative stress[J].Human Molecular Genetics,2017,26(10):1915-1926.
[9] Salvatori I,Valle C,Ferri A,et al.Sirt3 and mitochondrial metabolism in neurodegenerative diseases[J].Neurochemistry International,2017,109:184.
[10] Anand R,Gill KD,Mahdi AA.Therapeutics of Alzheimer's disease:Past,present and future[J].Neuropharmacology,2014,76(Pt A):27-50.
[11] Iijima K,Liu HP,Chiang AS,et al.Dissecting the pathological effects of human abeta40 and abeta42 in drosophila:A potential model for Alzheimer's disease[J].Proceedings of the National Academy of Sciences of the United States of America,2004,101(17):6623-6628.
[12] Lopez-Noguerola JS,Giessen NME,Ueberück M,et al.Synergistic effect on neurodegeneration by N-Truncated Aβ4-42 and pyroglutamate Aβ3-42 in a mouse model of Alzheimer's disease[J].Frontiers in Aging Neuroscience,2018,10:64.
[13] Iwatsubo T.Aβ42,presenilins,and Alzheimer's disease[J].Neurobiology of Aging,1998,19(s1):s11.
[14] Boche D,Zotova E,Weller RO,et al.Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain[J].Brain A Journal of Neurology,2008,131(Pt 12):3299.
[15] Inna K,Kerensa B,Iryna B,et al.Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio[J].Embo Journal,2014,29(19):3408-3420.
[16] Averbuch NS,França M,Lazar L,et al.An incidental finding of thyroid hormone resistance due to a de novo mutation in the THRB gene[J].Thyroid,2019,1:291.
[17] Jones I,Srinivas M,Ng L,et al.The thyroid hormone receptor beta gene:structure and functions in the brain and sensory systems[J].Thyroid Official Journal of the American Thyroid Association,2003,13(11):1057.
[18] Ng L,Rüsch A,Amma LL,et al.Suppression of the deafness and thyroid dysfunction in Thrb-null mice by an independent mutation in the thra thyroid hormone receptor alpha gene[J].Human Molecular Genetics,2001,10(23):2701-2708.
[19] Onyango P,Celic I,Mccaffery JM,et al.Sirt3,a human SIR2 homologue,is an NAD-dependent deacetylase localized to mitochondria[J].Proceedings of the National Academy of Sciences of the United States of America,2002,99(21):13653-13658.
[20] Shinichi S,Wei Y,Hallows WC,et al.Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction[J].Cell,2010,143(5):802-812.
[21] Swerdlow RH,Burns JM,Khan SM.The Alzheimer's disease mitochondrial cascade hypothesis:Progress and perspectives[J].Biochim Biophys Acta,2014,1842(8):1219-1231.
[22] Elkamhawy A,Park JE,Hassan AHE,et al.Synthesis and evaluation of 2-(3-arylureido)pyridines and 2-(3-arylureido)pyrazines as potential modulators of Aβ-induced mitochondrial dysfunction in Alzheimer's disease[J].European Journal of Medicinal Chemistry,2017,144:529-543.
[23] Li H,Jia J,Wang W,et al.Honokiol alleviates cognitive deficits of Alzheimer's disease(PS1V97L)transgenic mice by activating mitochondrial SIRT3[J].Journal of Alzheimer's Disease,2018,64(1):291-302.
[24] 屈红艳,邢文文,李 璐,等.针灸调节阿尔茨海默病患者线粒体Sirt3机制初探[J].陕西中医,2019,40(2):244-246.